Literature DB >> 20514551

Fluorescence spectroscopic determination of the critical aggregation concentration of the GnRH antagonists Cetrorelix, Teverelix and Ozarelix.

Alexander Schneider1, Alexander Lang, Wolfgang Naumann.   

Abstract

The fluorescence spectroscopic behavior of three 2-naphthylalanine containing Gonadotropin-releasing hormone (GnRH) antagonists Cetrorelix, Teverelix and Ozarelix has been investigated concerning their aggregation process in comparison to the non-aggregating peptide D-Phe(6)-GnRH. The aim of the present investigation consisted in developing a method to determine the critical aggregation concentration for these decapeptides. This was achieved by monitoring the incorporation of the fluorescent probe 1-anilino-8-naphthalene sulfonate (ANS) into aggregates and utilizing the modification of band shape and intensity of the intrinsic peptide fluorescence emission depending on the analyzed peptide concentrations. Finally an approach for the explanation of the observed band characteristics is presented analyzing the fluorescence of fragments Cetrorelix(1-4) and Cetrorelix(1-6).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20514551     DOI: 10.1007/s10895-010-0674-5

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  19 in total

1.  Synthesis and hydrolysis by cathepsin B of fluorogenic substrates with the general structure benzoyl-X-ARG-MCA containing non-natural basic amino acids at position X.

Authors:  R L Melo; R C Barbosa Pozzo; L C Alves; E Perissutti; G Caliendo; V Santagada; L Juliano; M A Juliano
Journal:  Biochim Biophys Acta       Date:  2001-05-05

Review 2.  Clinical use of GnRH analogues.

Authors:  L A Kiesel; A Rody; R R Greb; A Szilágyi
Journal:  Clin Endocrinol (Oxf)       Date:  2002-06       Impact factor: 3.478

3.  The fluorescence of tyrosine in alkaline solution.

Authors:  J L CORNOG; W R ADAMS
Journal:  Biochim Biophys Acta       Date:  1963-05-21

4.  Ultraviolet fluorescence of the aromatic amino acids.

Authors:  F W TEALE; G WEBER
Journal:  Biochem J       Date:  1957-03       Impact factor: 3.857

5.  Anomalous tyrosine emission at 331 nm in adrenal two iron and two labile-sulfur protein (adrenodoxin): a possible tyrosine exciplex.

Authors:  T Kimura; J Ting
Journal:  Biochem Biophys Res Commun       Date:  1971-12-03       Impact factor: 3.575

6.  Tyrosinate fluorescence maxima at 345 nm in proteins lacking tryptophan at pH 7.

Authors:  A G Szabo; K R Lynn; D T Krajcarski; D M Rayner
Journal:  FEBS Lett       Date:  1978-10-15       Impact factor: 4.124

7.  1-anilino-8-naphthalene sulfonate as a protein conformational tightening agent.

Authors:  D Matulis; C G Baumann; V A Bloomfield; R E Lovrien
Journal:  Biopolymers       Date:  1999-05       Impact factor: 2.505

Review 8.  Hypothalamic hormones and cancer.

Authors:  A V Schally; A M Comaru-Schally; A Nagy; M Kovacs; K Szepeshazi; A Plonowski; J L Varga; G Halmos
Journal:  Front Neuroendocrinol       Date:  2001-10       Impact factor: 8.606

Review 9.  New derivatives of GnRH as potential anticancer therapeutic agents.

Authors:  Gábor Mezo; Marilena Manea; Ildikí Szabí; Borbála Vincze; Magdolna Kovács
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

10.  Conformation prediction and spectral studies on adrenodoxin. The accessibility of the tyrosine residue at position 82 in the polypeptide.

Authors:  B T Lim; T Kimura
Journal:  J Biol Chem       Date:  1981-05-10       Impact factor: 5.157

View more
  3 in total

1.  Receptor-Based Peptides for Inhibition of Leukotoxin Activity.

Authors:  Eric Krueger; Shannon Hayes; En Hyung Chang; Shailagne Yutuc; Angela C Brown
Journal:  ACS Infect Dis       Date:  2018-05-17       Impact factor: 5.084

2.  Development and Validation of a Reversed-phase HPLC Method for Assay of the Decapeptide Cetrorelix Acetate in Bulk and Pharmaceutical Dosage Forms.

Authors:  Shirin Hooshfar; Seyed Alireza Mortazavi; Mohammad Piryaei; Hossein Ramandi Darzi; Nahid Shahsavari; Farzad Kobarfard
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

3.  Aggregation Behavior of Structurally Similar Therapeutic Peptides Investigated by 1H NMR and All-Atom Molecular Dynamics Simulations.

Authors:  Johanna Hjalte; Shakhawath Hossain; Andreas Hugerth; Helen Sjögren; Marie Wahlgren; Per Larsson; Dan Lundberg
Journal:  Mol Pharm       Date:  2022-02-01       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.